ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
21.277,92
1,12%
S&P 500
6.049,24
0,88%
Dow Jones
44.025,81
1,24%
Euro vs US Dollar
1,04524
0,45%
Bitcoin
105.093,75
-1,02%
Pepperstone
Advertisement
Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ

  6. ProMIS Neurosciences Inc (PMN) Börsenkurse

ProMIS Neurosciences Inc

ProMIS Neurosciences Inc (PMN)

ProMIS Neurosciences Inc
0,988999
0,0989
(11,11%)
Geschlossen 22 Januar 10:00PM
Verzögert um 15 Minuten
0,988999
0,00
( 0,00% )
Vor Marktöffnung: 10:51AM
Verzögert um 15 Minuten

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Premium

Wichtige Statistiken und Details

Current Price
0,988999
Gebot
0,816
Fragen
1,15
Volumen
-
0,00 Tagesbereich 0,00
0,87 52-Wochen-Bereich 2,61
Marktkapitalisierung
29,557M
Handelsende
0,988999
Handelsbeginn
-
Letzte Trade
Letzter Handelszeitpunkt
-
Finanzvolumen
-
VWAP
-
Durchschnittliches Volumen (3 Mio.)
75.208
Ausgegebene Aktien
29.885.452
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-13,57
Gewinn pro Aktie (EPS)
-0,44
Erlöse
-
Nettogewinn
-13,21M

Über ProMIS Neurosciences Inc

ProMIS Neurosciences Inc is focused on the discovery and development of precision medicine solutions for early detection and effective treatment of neurodegenerative diseases, including Alzheimer's disease, amyotrophic lateral sclerosis, and multiple system atrophy. The company also plans to investi... ProMIS Neurosciences Inc is focused on the discovery and development of precision medicine solutions for early detection and effective treatment of neurodegenerative diseases, including Alzheimer's disease, amyotrophic lateral sclerosis, and multiple system atrophy. The company also plans to investigate additional synucleionapathies, including Parkinson's disease, and dementia with Lewy bodies. It primarily operates in Canada. Mehr anzeigen

Sektor
Pharmaceutical Preparations
Branche
Pharmaceutical Preparations
Website
www.promisneurosciences.com
Hauptsitz
Toronto, Ontario, Can
Gegründet
-
ProMIS Neurosciences Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker PMN. The last closing price for ProMIS Neurosciences was US$0,99. Over the last year, ProMIS Neurosciences shares have traded in a share price range of US$ 0,87 to US$ 2,61.

ProMIS Neurosciences currently has 29.885.452 shares in issue. The market capitalisation of ProMIS Neurosciences is US$29,56 million. ProMIS Neurosciences has a price to earnings ratio (PE ratio) of -13.57.

PMN Neueste Nachrichten

Weitere Nachrichten

ProMIS Neurosciences Issues Letter to Shareholders

CAMBRIDGE, Massachusetts, Jan. 13, 2025 (GLOBE NEWSWIRE) -- ProMIS Neurosciences Inc. (Nasdaq: PMN) (ProMIS), a clinical-stage biotechnology company focused on the generation and development of...

13 Januar 2025
GlobeNewswire Inc.

Form 8-K - Current report

10 Januar 2025
Edgar (US Regulatory)

ProMIS Neurosciences Initiates Phase 1b Clinical Trial (PRECISE-AD) in Alzheimer’s Disease

CAMBRIDGE, Massachusetts, Jan. 10, 2025 (GLOBE NEWSWIRE) -- ProMIS Neurosciences Inc. (Nasdaq: PMN), a clinical-stage biotechnology company focused on developing precision therapies for...

10 Januar 2025
GlobeNewswire Inc.

Form 8-K - Current report

08 Januar 2025
Edgar (US Regulatory)

ProMIS Neurosciences to Participate in 7th Annual Evercore HealthCONx Conference

CAMBRIDGE, Massachusetts and TORONTO, Ontario, Nov. 26, 2024 (GLOBE NEWSWIRE) -- ProMIS Neurosciences Inc. (Nasdaq: PMN), a clinical-stage biotechnology company focused on the generation and...

26 November 2024
GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities

21 November 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

21 November 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

21 November 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

21 November 2024
Edgar (US Regulatory)

Form SC 13G - Statement of Beneficial Ownership by Certain Investors

14 November 2024
Edgar (US Regulatory)
Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10.0754998.264805692390.91351.020.879413730.9202154CS
40.0589996.343978494620.931.130.879526630.98332256CS
12-0.071001-6.698207547171.061.570.87752081.03873856CS
26-0.981001-49.79700507611.972.20.871163481.35727768CS
52-1.221001-55.24891402712.212.610.87654481.42873475CS
156-5.951001-85.74929394816.949.80.87677933.32310166CS
260-5.951001-85.74929394816.949.80.87677933.32310166CS

PMN - Frequently Asked Questions (FAQ)

What is the current ProMIS Neurosciences share price?
The current share price of ProMIS Neurosciences is US$ 0,988999
How many ProMIS Neurosciences shares are in issue?
ProMIS Neurosciences has 29.885.452 shares in issue
What is the market cap of ProMIS Neurosciences?
The market capitalisation of ProMIS Neurosciences is USD 29,56M
What is the 1 year trading range for ProMIS Neurosciences share price?
ProMIS Neurosciences has traded in the range of US$ 0,87 to US$ 2,61 during the past year
What is the PE ratio of ProMIS Neurosciences?
The price to earnings ratio of ProMIS Neurosciences is -13,57
What is the reporting currency for ProMIS Neurosciences?
ProMIS Neurosciences reports financial results in USD
What is the latest annual profit for ProMIS Neurosciences?
The latest annual profit of ProMIS Neurosciences is USD -13,21M
What is the registered address of ProMIS Neurosciences?
The registered address for ProMIS Neurosciences is SUITE 200, 1920 YONGE STREET, TORONTO, ONTARIO, M4S 3E2
What is the ProMIS Neurosciences website address?
The website address for ProMIS Neurosciences is www.promisneurosciences.com
Which industry sector does ProMIS Neurosciences operate in?
ProMIS Neurosciences operates in the PHARMACEUTICAL PREPARATIONS sector

Beweger

Alle Anzeigen
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
ASSTAsset Entities Inc
US$ 1,64
(82,22%)
19,25M
BBGIBeasley Broadcast Group Inc
US$ 13,93
(62,92%)
203
IROHIron Horse Acquisition Corporation
US$ 16,44
(58,99%)
14
FUSBFirst US Bancshares Inc
US$ 19,99
(53,89%)
8
CHCIComstock Holding Companies Inc
US$ 11,99
(44,63%)
7
ABLAbacus Life Inc
US$ 3,01
(-59,97%)
32
RMBIRichmond Mutual Bancorporation Inc
US$ 8,01
(-40,31%)
1
IZTCInvizyne Technologies Inc
US$ 7,02
(-37,88%)
15
HUBCHub Cyber Security Ltd
US$ 0,555
(-34,32%)
239,74k
GLACGlobal Lights Acquisition Corporation
US$ 7,30
(-31,78%)
6
ASSTAsset Entities Inc
US$ 1,64
(82,22%)
19,25M
IPAImmunoPrecise Antibodies Ltd
US$ 0,6143
(24,60%)
18,71M
CDIOCardio Diagnostics Holdings Inc
US$ 0,7262
(19,44%)
10,34M
RIMEAlgorhythm Holdings Inc
US$ 0,0356
(2,89%)
10,27M
USEGUS Energy Corp
US$ 5,47
(44,33%)
5,52M

Foren

Foren anzeigen
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

NASDAQ
PMN
ProMIS Neurosciences
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2025 ADVFN PLC - Alle Rechte vorbehalten